Press release
The Pharmaceutical R&D Outsourcing Market on Track for $150 Billion Milestone, North America Takes the Spotlight - Arizton
Pharmaceutical R&D Outsourcing Market Research Report by Arizton
Looking for More Information? Click: https://www.arizton.com/market-reports/pharma-rd-outsourcing-market
Report Scope:
Market Size (2029): $150.04 Billion
Market Size (2023): $84.01 Billion
CAGR (2023-2029): 10.15%
Historic Year: 2020-2022
Base Year: 2023
Forecast Year: 2024-2029
Market Segmentation: Stage of Development, Product Type, Company Size, Therapy Area, and Geography
Geographical Analysis: North America, Europe, APAC, Latin America, And Middle East & Africa
The pharmaceutical R&D outsourcing market is witnessing significant growth, driven by rising demand for personalized treatments and advancements in biotechnology and precision medicine. Biologics, such as monoclonal antibodies, are gaining prominence in addressing high unmet needs in areas like oncology, dermatology, and immunology. Clinical trials play a critical role in drug development, with outsourcing to specialized CROs helping streamline processes and manage costs. Small molecules maintain market dominance due to their simpler design and synthesis compared to biologics. Small and mid-sized enterprises (SMEs) are emerging as key players, focusing on specialized therapeutic areas and becoming attractive partners for outsourcing. Oncology remains a major segment in R&D outsourcing, supported by innovations in cell therapies, radiopharmaceuticals, and personalized medicine.
Role of Real-World Evidence (RWE) in Driving Pharmaceutical R&D Outsourcing Market Growth
The integration of Real-World Evidence (RWE) is significantly boosting the pharmaceutical R&D outsourcing market. RWE, derived from real-world data like electronic health records and patient-reported outcomes, enhances drug development by informing trial design, optimizing site selection, and identifying patient populations. It reduces reliance on traditional clinical trial methods, accelerates regulatory approvals, and addresses challenges in areas like rare diseases and advanced therapies. Outsourcing providers specializing in RWE-driven analytics are in demand as pharmaceutical companies leverage RWE to streamline processes, improve cost-efficiency, and deliver tailored treatments. This trend is fueling growth in R&D outsourcing across pre-market and post-market stages.
Small & Mid-Sized Companies: The Fastest-Growing Segment with a CAGR of 10.58%
Small and mid-sized companies play a crucial role in the global pharmaceutical R&D outsourcing market. These companies, facing rising costs and complexity in drug development, rely on contract research organizations (CROs) for essential services like preclinical research, clinical trials, and regulatory support. This collaboration allows them to remain competitive without extensive in-house resources. Notable firms like Emulate, Inc. and Fate Therapeutics have gained attention for their innovative technologies in drug testing and immunotherapy. The demand for CRO services is especially strong in Europe and APAC, where cost advantages and skilled labor drive the growth of outsourced R&D.
North America Leading the Global Pharmaceutical R&D Outsourcing Market
In 2023, North America captured 35.93% of the global pharmaceutical R&D outsourcing market and is projected to grow significantly during the forecast period. The region benefits from a strong infrastructure, skilled workforce, and a thriving ecosystem of CROs and CMOs, supported by industry leaders like IQVIA, Catalent, and Lonza. Companies increasingly outsource R&D activities to focus on innovation and reduce operational burdens, with a notable demand from biotech firms lacking in-house resources. Advanced technologies like AI and cloud computing further streamline drug development processes, solidifying North America's position as a key player in this market through 2030 and beyond.
Recent Vendors Activities
* In 2024, Boehringer Ingelheim expanded its oncology portfolio by acquiring preclinical assets from Nerio Therapeutics to develop innovative checkpoint inhibitors for cancer, in a deal worth up to USD 1.3 billion.
* The company also partnered with Ochre Bio to advance liver regeneration treatments and novel therapies for chronic liver diseases, with the collaboration valued at over USD 1 billion.
* In 2024, AbbVie announced a definitive agreement to acquire Aliada, a biotechnology company specializing in therapies for central nervous system (CNS) diseases. Aliada's innovative blood-brain barrier (BBB)-crossing technology is at the core of its approach, offering potential breakthroughs in CNS treatment.
* In 2024, Merck acquired Modifi Biosciences Inc., a company specializing in cancer therapeutics driven by direct DNA modification technology.
Explore More! [https://www.arizton.com/market-reports/pharma-rd-outsourcing-market]
Key Vendors
* Boehringer Ingelheim
* Charles River Laboratories
* ICON
* IQVIA
* Fortrea
* Lonza
* Medpace
* Parexel International Corp
* Samsung Biologics
* Syneos Health
* Thermo Fisher Scientific
* WuXi AppTec
* AbbVie
* ProtaGene
* Asymchem Laboratories
* Alcami
* Bavarian Nordic
* Catalent
* Curia Global
* ChemPartner
* Aixial Group
* Criterium
* Cromos Pharma
* Evotec
* Jubilant HollisterStier
* KBI Biopharma
* KCR S.A.
* Kemwell Biopharma
* Mesned Pharma Consult Center (MPCC)
* Midas Pharma
* Medelis
* Merck KGaA
* OCT Clinical
* Pharmaceutics International
* ProTrials Research
* Prometrika
* QPS
* Singota Solutions
* Sofpromed
* Sanofi S.A.
* Taros Chemicals
* Veristat
* Worldwide Clinical Trials
* Wacker Biotech
Segmentation & Forecast
Stage of Development
* Clinical
* Non-clinical
Product Type
* Small Molecules
* Biologics
Company Size
* Small & Mid-sized Companies
* Large Companies
Therapy Area
* Oncology
* Cardiovascular Diseases
* Infectious Diseases
* Musculoskeletal Disorders
* Central Nervous System Disorders
* Gastrointestinal Disorders
* Others
Geography
North America
* The US
* Canada
Europe
* Germany
* The UK
* France
* Italy
* Spain
APAC
* China
* Japan
* India
* Australia
* South Korea
Latin America
* Brazil
* Mexico
* Argentina
Middle East & Africa
* Turkey
* Saudi Arabia
* South Africa
* The UAE
The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the global pharmaceutical R&D outsourcing market. Request for Free Sample to get a glance of the report now: [https://www.arizton.com/market-reports/pharma-rd-outsourcing-market]
What Key Findings Our Research Analysis Reveals?
How large is the global pharmaceutical R&D outsourcing market?
Which product has the largest share of the global pharmaceutical R&D outsourcing market?
What are the latest trends in the global pharmaceutical R&D outsourcing market?
Who are the key players in the global pharmaceutical R&D outsourcing market?
Which shows the highest growth in the global pharmaceutical R&D outsourcing market?
Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4631
Other Related Reports that Might be of Your Business Requirement
U.S. Pharmacy Benefit Management Market - Industry Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/pharmacy-benefit-management-market-in-united-states
IVD Contract Manufacturing Market - Global Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/ivd-contract-manufacturing-market
Why Arizton?
100%Customer Satisfaction
24x7availability - we are always there when you need us
200+Fortune 500 Companies trust Arizton's report
80%of our reports are exclusive and first in the industry
100%more data and analysis
1500+reports published till date
Post-Purchase Benefit
* 1hr of free analyst discussion
* 10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-pharmaceutical-rd-outsourcing-market-on-track-for-150-billion-milestone-north-america-takes-the-spotlight-arizton]
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/pharma-rd-outsourcing-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Pharmaceutical R&D Outsourcing Market on Track for $150 Billion Milestone, North America Takes the Spotlight - Arizton here
News-ID: 3809826 • Views: …
More Releases from ABNewswire
Uplers Highlights 2025 Trend: Brands Compete to Hire Graphic Designers With Adva …
The design industry is entering a new era in 2025 and the years to come. Creativity and artificial intelligence are merging to reshape how visual content is being produced. For brands, this no longer is a trend to monitor, instead it's a race to secure the right and skilled talent. Companies are fiercely competing to hire graphic designers who can harness AI tools to deliver innovation, speed, and consistency across…
Inside Uplers Latest Report: What Companies Should Know About Angular Developer …
Angular continues to be one of the widely adopted front-end frameworks for dynamic and scalable app development. With digital products becoming increasingly complex, global hiring managers are continuing to face the challenge of finding Angular talent for balancing cost and availability.
In response to this, Uplers is publishing new salary insights based on the evolving hiring trends for supporting companies in shaping their competitive strategies to hire Angular developers [https://www.uplers.com/hire-angularjs-developers/]. The…
The Moss Way: Unlocking the True Power of Irish Sea Moss for Modern Wellness
London, United Kingdom - 7 Oct, 2025 - As the wellness industry evolves, a growing number of people are turning back to nature's timeless remedies - and few are as powerful or as misunderstood as Irish Sea Moss. Leading this natural health renaissance is The Moss Way, a UK-based wellness brand redefining what it means to nourish the body with pure, sustainably sourced superfoods. With a focus on authenticity, science,…
New Outdoor Retailer Feeling My Adventure Empowers Digital Detox Through Compreh …
The outdoor retail sector welcomes Feeling My Adventure, a new e-commerce venture operated by Ingrid K Santana Ramirez LLC, offering comprehensive equipment solutions for camping, survival preparedness, and outdoor recreation activities. Launching at feelingmyadventure.com, the platform distinguishes itself through a philosophy emphasizing nature's role in personal restoration and the importance of disconnecting from digital saturation to rediscover authentic human experiences.
Market timing for the launch aligns with growing societal recognition of…
More Releases for R&D
Sales Acceleration Technology Market 2023: Sales and Industry Revenue Forecasts- …
The Sales Acceleration Technology market has witnessed growth from USD XX million to USD XX million from 2017 to 2023. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Sales Acceleration Technology market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological…
R&D Incentive Services Market is Booming Worldwide | KPMG, R&D Incentives, Deloi …
The latest report released on Global R&D Incentive Services Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the R&D Incentive Services Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend, growth factors and estimates for Global R&D Incentive Services Market forecasted till 2028. Some of the key players profiled are KPMG…
Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in…
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward.
This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry.
Power Assemblies, Controllers and…
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer.
Precision/Fine Mechanics
For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who:
Is mechanically skilled with a focus on very small machinery.
Holds a technical high school degree or an apprenticeship…
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University…
